Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicASX:MSB
Date3/2013
Raised$170M
Post IPO Valuation

General Information

Offices

Melbourne, AUS
Level 39
55 Collins Street
Melbourne, 3000, AUS

People

COO
CFO
Vice President, Operations
Director

Acquisitions

Tags

Mesoblast

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast’s patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, orthopedic spine conditions, and cardiovascular disorders.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Mesoblast to acquire Angioblast and speed up stem cell work (fiercebiotech.com) [edit]
  2. Mesoblast Limited (MSB.AX) Snags Osiris Therapeutics, Inc. (OSIR)'s Stem Cell Assets for Up to $100 Million (biospace.com) [edit]
Edit This Page
Last Edited 10/13/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy